ASND: Prakiraan pendapatan perusahaan Ascendis Pharma A/S

Ascendis Pharma A/S (ASND) develops innovative therapies for metabolic disorders, utilizing the TransCon platform to create long-acting medicines. The revenue forecast demonstrates the company's resilience, where the 0.99 level represents the current value. High patent barriers and strict FDA oversight protect the business, while diversified supply chains in the US and Europe guarantee stable drug deliveries.

Prakiraan pendapatan perusahaan: Ascendis (ASND) kanggo 04.07.2022 - 13.11.2026

Rincian analitis lan laporan data perusahaan Ascendis Pharma AS (ASND)

- kuotasi lan prakiraan analis:

Rega saham Ascendis Pharma A/S|ASND - Bagan rega target

- informasi kapitalisasi pasar:

Nilai pasar Ascendis Pharma AS|ASND - Total Nilai Perusahaan

- data ekuitas miturut neraca:

Aset Bersih saben Siji Saham Ascendis Pharma|ASND - Nilai Buku Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ascendispharma.com|ASND - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas Ascendis Pharma A/S|ASND - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ascendis Pharma Inc.|ASND - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Ascendis Pharma AS|ASND - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ascendis Pharma|Rasio cepet ascendispharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

ASND - Penghasilan resik|Proyeksi bathi mangsa ngarep Ascendis Pharma A/S|ASND - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Ascendis Pharma|ASND - Rasio P/E diaturake wutah|Pangali EV/EBITDA Ascendis Pharma AS|ASND - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Ascendis Pharma|ASND - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ascendispharma.com|ASND - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Ascendis Pharma A/S

- rincian pendapatan lan dodolan emiten:

ASND - Pendapatan dodolan perusahaan|Prakiraan pendapatan perusahaan Ascendis Pharma A/S|ASND - Rasio rega marang dodolan|Multiplikator Forward P/S Ascendis Pharma AS

Analisis fundamental perusahaan:Ascendis Pharma A/S

Driven by patents for long-acting hormones and a lack of competitors, Ascendis Pharma A/S (ASND) possesses significant pricing power that directly impacts cash flows. This indicator aggregates revenue expectations, accounting for macroeconomic demand and premium product positioning, which allows for an assessment of risks regarding business deviation from a sustainable yield range via the company's projected sales volume.

Analisis perusahaan pesaing